Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Obesity and Nonalcoholic Fatty Liver Disease: Complete Statistical AnalysisIndependent statistical analysis of Obesity and Nonalcoholic Fatty Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00262964).
- Obesity, Sleep Apnea, and Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Obesity, Sleep Apnea, and Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02192684).
- Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma: Complete Statistical AnalysisIndependent statistical analysis of Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Data Analysis in EuroSIDA (MK-0518-058): Complete Statistical AnalysisIndependent statistical analysis of Observational Data Analysis in EuroSIDA (MK-0518-058): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01078233).
- Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.: Complete Statistical AnalysisIndependent statistical analysis of Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00531206).
- Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study): Complete Statistical AnalysisIndependent statistical analysis of Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema: Complete Statistical AnalysisIndependent statistical analysis of Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Observational Study of Anti-Reflux Surgery: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Anti-Reflux Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01624506).
- Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice: Complete Statistical AnalysisIndependent statistical analysis of Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: Complete Statistical AnalysisIndependent statistical analysis of Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD: Complete Statistical AnalysisIndependent statistical analysis of Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: Complete Statistical AnalysisIndependent statistical analysis of Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Observational Trial With Enbrel: Complete Statistical AnalysisIndependent statistical analysis of Observational Trial With Enbrel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00488475).
- OBSERVE-IVAIndependent statistical analysis of Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Obstructive Sleep Apnea in World Trade Center Responders: Complete Statistical AnalysisIndependent statistical analysis of Obstructive Sleep Apnea in World Trade Center Responders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01753999).
- Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific: Complete Statistical AnalysisIndependent statistical analysis of Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific: primary endpoint results, effect estimate…
- OCEANIndependent statistical analysis of A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OCRIndependent statistical analysis of A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- OCTAVEIndependent statistical analysis of A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease: Complete Statistical AnalysisIndependent statistical analysis of Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ODEIIndependent statistical analysis of The Opening Doors to Early Intervention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03625115).
- ODYSSEY HoFHIndependent statistical analysis of Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03156621).
- Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin’s Lymphoma (B-NHL): Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01258933).
- Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL: Complete Statistical AnalysisIndependent statistical analysis of Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Off Clamp Randomization: Complete Statistical AnalysisIndependent statistical analysis of Off Clamp Randomization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01732120).
- Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia: Complete Statistical AnalysisIndependent statistical analysis of Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01408732).
- OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone: Complete Statistical AnalysisIndependent statistical analysis of OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- OHR-3Independent statistical analysis of Safety for Frequent Use Conditions of Hair Removal Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01348789).
- OIIndependent statistical analysis of Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OISO-1Independent statistical analysis of Comparison of Three Techniques for Ultrasound-guided Internal Jugular Cannulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01966354).
- OKQ2Independent statistical analysis of One Key Question: Pilot Study at NorthShore: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03947788).
- Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with…
- Olaparib in Adults With Recurrent/Metastatic Ewing’s Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01583543).
- Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05286827).
- Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- OLE-IEDATIndependent statistical analysis of Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10): Complete Statistical AnalysisIndependent statistical analysis of Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01294241).
- OLIFIndependent statistical analysis of OptiMesh® for Lumbar Interbody Fusion Trial (OLIF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00764491).
- oligo-metsIndependent statistical analysis of A Study of Definitive Therapy to Treat Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02716974).
- OLIGOPELVISIndependent statistical analysis of Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…